Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HEAL STUDY (Hepatic Encephalopathy and Albumin Study): A Double-Blind Randomized Controlled Trial Of Albumin In Hepatic Encephalopathy

NCT03585257 is registered in ClinicalTrials.gov with Hunter Holmes Mcguire Veteran Affairs Medical Center as lead sponsor.

NCT NCT03585257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HEAL STUDY (Hepatic Encephalopathy and Albumin Study): A Double-Blind Randomized Controlled Trial Of Albumin In Hepatic Encephalopathy
Lead sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Phase
Phase 2
Overall status
Completed
Start date
June 20, 2018
Completion date
March 30, 2022
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, covert hepatic encephalopathy, hepatic encephalopathy, minimal hepatic encephalopathy